Initial adherence to autotitrating positive airway pressure therapy: influence of upper airway narrowing
- PMID: 20072692
- PMCID: PMC2804093
- DOI: 10.3342/ceo.2009.2.4.181
Initial adherence to autotitrating positive airway pressure therapy: influence of upper airway narrowing
Abstract
Objectives: There is still debate concerning the reason for the high initial failure rate of positive airway pressure (PAP) treatment. The objective of this study is to investigate the factors of the initial adherence to PAP, with an emphasis on the role of upper airway narrowing.
Methods: The patients were divided into two groups according to the continuation of therapy within the first three months of treatment. The demographic and polysomnographic findings, the minimal nasal cross sectional area (MCA), the degree of palatine tonsilar hypertrophy (PTH) and the modified Mallampati grade of the oropharynx inlet (Orophx) were compared between the study groups.
Results: Among 36 patients, 23 continued the auto-adjusting positive airway pressure (APAP) therapy (the adherent group) and 13 discontinued APAP within three months (the non-adherent group). The apnea-hypopnea index (AHI) was significantly higher in the adherent group than in the non-adherent group (P<0.001). The AHI distributions of the two groups are extremely different. Thirteen of the 23 patients in the adherent group had an AHI of more than 60/hr, while none of the patients in the non-adherent group had an AHI of more than 60/hr. In the patients with an AHI from 15 to 60/hr, the MCA at the wide side of the nasal cavity and the sum of the MCAs of both sides were significantly larger in the adherent group than those values in the non-adherent group (P=0.004). The PTH and the Orophx were not significantly different between the two groups.
Conclusion: AHI is a definite significant factor of adherence to APAP therapy. The dimension of the nasal cavity has an influence on initial APAP adherence in the patients who have a not too high level of AHI.
Keywords: Adherence; Compliance; Continuous positive airway pressure; Nasal cavity; Upper airway.
Similar articles
-
Comparison of 3-months treatment adherence and estimating residual apnea hypopnea index between home versus in-laboratory auto-titrating positive airway pressure titration.Clin Respir J. 2020 Jul;14(7):622-630. doi: 10.1111/crj.13174. Epub 2020 Mar 10. Clin Respir J. 2020. PMID: 32107871 Clinical Trial.
-
NightBalance Sleep Position Treatment Device Versus Auto-Adjusting Positive Airway Pressure for Treatment of Positional Obstructive Sleep Apnea.J Clin Sleep Med. 2019 Jul 15;15(7):947-956. doi: 10.5664/jcsm.7868. J Clin Sleep Med. 2019. PMID: 31383231 Free PMC article. Clinical Trial.
-
Baseline Lighter Sleep and Lower Saturation Are Associated With Improved Sleepiness and Adherence on Continuous Rather Than Autotitrating Positive Airway Pressure.Clin EEG Neurosci. 2020 May;51(3):174-179. doi: 10.1177/1550059419892759. Epub 2019 Dec 18. Clin EEG Neurosci. 2020. PMID: 31852280
-
Predictors of adherence to positive airway pressure therapy in children: a systematic review and meta-analysis.Sleep Med. 2020 May;69:19-33. doi: 10.1016/j.sleep.2019.12.015. Epub 2020 Jan 11. Sleep Med. 2020. PMID: 32045851
-
The use of auto-titrating continuous positive airway pressure for treatment of adult obstructive sleep apnea. An American Academy of Sleep Medicine review.Sleep. 2002 Mar 15;25(2):148-73. Sleep. 2002. PMID: 11902425 Review.
Cited by
-
Nasal involvement in obstructive sleep apnea syndrome.Int J Otolaryngol. 2014;2014:717419. doi: 10.1155/2014/717419. Epub 2014 Nov 20. Int J Otolaryngol. 2014. PMID: 25548569 Free PMC article. Review.
-
Positive airway pressure initiation: a randomized controlled trial to assess the impact of therapy mode and titration process on efficacy, adherence, and outcomes.Sleep. 2011 Aug 1;34(8):1083-92. doi: 10.5665/SLEEP.1166. Sleep. 2011. PMID: 21804670 Free PMC article. Clinical Trial.
-
The influence of nasal abnormalities in adherence to continuous positive airway pressure device therapy in obstructive sleep apnea patients. What role does the nose play?Sleep Breath. 2015 Mar;19(1):5-6. doi: 10.1007/s11325-014-0970-4. Epub 2014 Mar 18. Sleep Breath. 2015. PMID: 24638263 No abstract available.
-
Effect of uvulopalatopharyngoplasty on CPAP compliance.Eur Arch Otorhinolaryngol. 2015 Jun;272(6):1437-42. doi: 10.1007/s00405-014-3239-4. Epub 2014 Aug 10. Eur Arch Otorhinolaryngol. 2015. PMID: 25108341
-
Nasal function and CPAP use in patients with obstructive sleep apnoea: a systematic review.Sleep Breath. 2022 Sep;26(3):1321-1332. doi: 10.1007/s11325-021-02478-x. Epub 2021 Sep 2. Sleep Breath. 2022. PMID: 34476729
References
-
- Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. American Thoracic Society: official statement adopted March 1944. Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1738–1745. - PubMed
-
- Rolfe I, Olson LG, Saunders NA. Long-term acceptance of continuous positive airway pressure in obstructive sleep apnea. Am Rev Respir Dis. 1991 Nov;144(5):1130–1133. - PubMed
-
- Kim HY, Min JY, Cho DY, Chung SK, Dhong HJ. Influence of upper airway narrowing on the effective continuous positive airway pressure level. Laryngoscope. 2007 Jan;117(1):82–85. - PubMed
-
- Sugiura T, Noda A, Nakata S, Yasuda Y, Soga T, Miyata S, et al. Influence of nasal resistance on initial acceptance of continuous positive airway pressure in treatment for obstructive sleep apnea syndrome. Respiration. 2007;74(1):56–60. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials